Global ADC Drug CDMO Service Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global ADC Drug CDMO Service market size was valued at US$ 2981 million in 2024 and is forecast to a readjusted size of USD 9685 million by 2031 with a CAGR of 18.6% during review period.
ADC drugs, also known as antibody drug coupling agents, work by coupling small molecule drugs with antibodies through linkers to form drugs. These drugs combine the high targeting ability of antibodies with the strong killing power of chemical drugs, and are considered the most promising next-generation antibody technology. To reduce research and development costs, most ADC drug development worldwide chooses outsourcing, leveraging CDMO companies to enter clinical and market more quickly. CDMO services refer to pharmaceutical and biotechnology companies outsourcing the research and production of their drugs or biological products to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its ability to customize and specialize, which can meet the specific needs of different customers at different stages.
One of the primary drivers of the ADC drug CDMO market is the increasing demand for targeted therapies, particularly in oncology. Cancer remains a leading cause of death globally, and the traditional methods of chemotherapy, while effective, often come with severe side effects that limit their use. ADCs, which combine the targeting ability of monoclonal antibodies with the potency of cytotoxic drugs, offer a more precise and effective treatment option. By delivering the toxic drug directly to cancer cells, ADCs minimize damage to healthy tissues, thereby reducing adverse effects.
The demand for ADCs is expected to increase significantly due to their ability to treat a wide range of cancers, including breast cancer, leukemia, and lung cancer. As the pipeline for ADC drugs continues to expand, pharmaceutical companies are increasingly relying on CDMOs to support the development and manufacturing of these complex therapies.
This report is a detailed and comprehensive analysis for global ADC Drug CDMO Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global ADC Drug CDMO Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global ADC Drug CDMO Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global ADC Drug CDMO Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global ADC Drug CDMO Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for ADC Drug CDMO Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global ADC Drug CDMO Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Merck KGaA, WuXi XDC, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, Axplora, Aji Bio-Pharma, BSP Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
ADC Drug CDMO Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe ADC Drug CDMO Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of ADC Drug CDMO Service, with revenue, gross margin, and global market share of ADC Drug CDMO Service from 2020 to 2025.
Chapter 3, the ADC Drug CDMO Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and ADC Drug CDMO Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of ADC Drug CDMO Service.
Chapter 13, to describe ADC Drug CDMO Service research findings and conclusion.
ADC drugs, also known as antibody drug coupling agents, work by coupling small molecule drugs with antibodies through linkers to form drugs. These drugs combine the high targeting ability of antibodies with the strong killing power of chemical drugs, and are considered the most promising next-generation antibody technology. To reduce research and development costs, most ADC drug development worldwide chooses outsourcing, leveraging CDMO companies to enter clinical and market more quickly. CDMO services refer to pharmaceutical and biotechnology companies outsourcing the research and production of their drugs or biological products to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its ability to customize and specialize, which can meet the specific needs of different customers at different stages.
One of the primary drivers of the ADC drug CDMO market is the increasing demand for targeted therapies, particularly in oncology. Cancer remains a leading cause of death globally, and the traditional methods of chemotherapy, while effective, often come with severe side effects that limit their use. ADCs, which combine the targeting ability of monoclonal antibodies with the potency of cytotoxic drugs, offer a more precise and effective treatment option. By delivering the toxic drug directly to cancer cells, ADCs minimize damage to healthy tissues, thereby reducing adverse effects.
The demand for ADCs is expected to increase significantly due to their ability to treat a wide range of cancers, including breast cancer, leukemia, and lung cancer. As the pipeline for ADC drugs continues to expand, pharmaceutical companies are increasingly relying on CDMOs to support the development and manufacturing of these complex therapies.
This report is a detailed and comprehensive analysis for global ADC Drug CDMO Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global ADC Drug CDMO Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global ADC Drug CDMO Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global ADC Drug CDMO Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global ADC Drug CDMO Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for ADC Drug CDMO Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global ADC Drug CDMO Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Merck KGaA, WuXi XDC, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, Axplora, Aji Bio-Pharma, BSP Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
ADC Drug CDMO Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cleavable Linkers
- Non-cleavable Linkers
- Small and Medium-sized Pharmaceutical Companies
- Large Pharmaceutical Companies
- Lonza Group
- Merck KGaA
- WuXi XDC
- Abbvie
- Piramal Pharma Solutions
- Catalent
- Sterling Pharma Solutions
- Axplora
- Aji Bio-Pharma
- BSP Pharmaceuticals
- Cerbios-Pharma
- Goodwin Biotechnology
- TOT Biopharm
- Huadong Medicine
- Innovent Biologics
- Shanghai Henlius Biotech
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe ADC Drug CDMO Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of ADC Drug CDMO Service, with revenue, gross margin, and global market share of ADC Drug CDMO Service from 2020 to 2025.
Chapter 3, the ADC Drug CDMO Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and ADC Drug CDMO Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of ADC Drug CDMO Service.
Chapter 13, to describe ADC Drug CDMO Service research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of ADC Drug CDMO Service by Type
1.3.1 Overview: Global ADC Drug CDMO Service Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global ADC Drug CDMO Service Consumption Value Market Share by Type in 2024
1.3.3 Cleavable Linkers
1.3.4 Non-cleavable Linkers
1.4 Global ADC Drug CDMO Service Market by Application
1.4.1 Overview: Global ADC Drug CDMO Service Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Small and Medium-sized Pharmaceutical Companies
1.4.3 Large Pharmaceutical Companies
1.5 Global ADC Drug CDMO Service Market Size & Forecast
1.6 Global ADC Drug CDMO Service Market Size and Forecast by Region
1.6.1 Global ADC Drug CDMO Service Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global ADC Drug CDMO Service Market Size by Region, (2020-2031)
1.6.3 North America ADC Drug CDMO Service Market Size and Prospect (2020-2031)
1.6.4 Europe ADC Drug CDMO Service Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific ADC Drug CDMO Service Market Size and Prospect (2020-2031)
1.6.6 South America ADC Drug CDMO Service Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa ADC Drug CDMO Service Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group ADC Drug CDMO Service Product and Solutions
2.1.4 Lonza Group ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA ADC Drug CDMO Service Product and Solutions
2.2.4 Merck KGaA ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 WuXi XDC
2.3.1 WuXi XDC Details
2.3.2 WuXi XDC Major Business
2.3.3 WuXi XDC ADC Drug CDMO Service Product and Solutions
2.3.4 WuXi XDC ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 WuXi XDC Recent Developments and Future Plans
2.4 Abbvie
2.4.1 Abbvie Details
2.4.2 Abbvie Major Business
2.4.3 Abbvie ADC Drug CDMO Service Product and Solutions
2.4.4 Abbvie ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Abbvie Recent Developments and Future Plans
2.5 Piramal Pharma Solutions
2.5.1 Piramal Pharma Solutions Details
2.5.2 Piramal Pharma Solutions Major Business
2.5.3 Piramal Pharma Solutions ADC Drug CDMO Service Product and Solutions
2.5.4 Piramal Pharma Solutions ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.6 Catalent
2.6.1 Catalent Details
2.6.2 Catalent Major Business
2.6.3 Catalent ADC Drug CDMO Service Product and Solutions
2.6.4 Catalent ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Catalent Recent Developments and Future Plans
2.7 Sterling Pharma Solutions
2.7.1 Sterling Pharma Solutions Details
2.7.2 Sterling Pharma Solutions Major Business
2.7.3 Sterling Pharma Solutions ADC Drug CDMO Service Product and Solutions
2.7.4 Sterling Pharma Solutions ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Sterling Pharma Solutions Recent Developments and Future Plans
2.8 Axplora
2.8.1 Axplora Details
2.8.2 Axplora Major Business
2.8.3 Axplora ADC Drug CDMO Service Product and Solutions
2.8.4 Axplora ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Axplora Recent Developments and Future Plans
2.9 Aji Bio-Pharma
2.9.1 Aji Bio-Pharma Details
2.9.2 Aji Bio-Pharma Major Business
2.9.3 Aji Bio-Pharma ADC Drug CDMO Service Product and Solutions
2.9.4 Aji Bio-Pharma ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Aji Bio-Pharma Recent Developments and Future Plans
2.10 BSP Pharmaceuticals
2.10.1 BSP Pharmaceuticals Details
2.10.2 BSP Pharmaceuticals Major Business
2.10.3 BSP Pharmaceuticals ADC Drug CDMO Service Product and Solutions
2.10.4 BSP Pharmaceuticals ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 BSP Pharmaceuticals Recent Developments and Future Plans
2.11 Cerbios-Pharma
2.11.1 Cerbios-Pharma Details
2.11.2 Cerbios-Pharma Major Business
2.11.3 Cerbios-Pharma ADC Drug CDMO Service Product and Solutions
2.11.4 Cerbios-Pharma ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Cerbios-Pharma Recent Developments and Future Plans
2.12 Goodwin Biotechnology
2.12.1 Goodwin Biotechnology Details
2.12.2 Goodwin Biotechnology Major Business
2.12.3 Goodwin Biotechnology ADC Drug CDMO Service Product and Solutions
2.12.4 Goodwin Biotechnology ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Goodwin Biotechnology Recent Developments and Future Plans
2.13 TOT Biopharm
2.13.1 TOT Biopharm Details
2.13.2 TOT Biopharm Major Business
2.13.3 TOT Biopharm ADC Drug CDMO Service Product and Solutions
2.13.4 TOT Biopharm ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 TOT Biopharm Recent Developments and Future Plans
2.14 Huadong Medicine
2.14.1 Huadong Medicine Details
2.14.2 Huadong Medicine Major Business
2.14.3 Huadong Medicine ADC Drug CDMO Service Product and Solutions
2.14.4 Huadong Medicine ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Huadong Medicine Recent Developments and Future Plans
2.15 Innovent Biologics
2.15.1 Innovent Biologics Details
2.15.2 Innovent Biologics Major Business
2.15.3 Innovent Biologics ADC Drug CDMO Service Product and Solutions
2.15.4 Innovent Biologics ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Innovent Biologics Recent Developments and Future Plans
2.16 Shanghai Henlius Biotech
2.16.1 Shanghai Henlius Biotech Details
2.16.2 Shanghai Henlius Biotech Major Business
2.16.3 Shanghai Henlius Biotech ADC Drug CDMO Service Product and Solutions
2.16.4 Shanghai Henlius Biotech ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Shanghai Henlius Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global ADC Drug CDMO Service Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of ADC Drug CDMO Service by Company Revenue
3.2.2 Top 3 ADC Drug CDMO Service Players Market Share in 2024
3.2.3 Top 6 ADC Drug CDMO Service Players Market Share in 2024
3.3 ADC Drug CDMO Service Market: Overall Company Footprint Analysis
3.3.1 ADC Drug CDMO Service Market: Region Footprint
3.3.2 ADC Drug CDMO Service Market: Company Product Type Footprint
3.3.3 ADC Drug CDMO Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global ADC Drug CDMO Service Consumption Value and Market Share by Type (2020-2025)
4.2 Global ADC Drug CDMO Service Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2025)
5.2 Global ADC Drug CDMO Service Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America ADC Drug CDMO Service Consumption Value by Type (2020-2031)
6.2 North America ADC Drug CDMO Service Market Size by Application (2020-2031)
6.3 North America ADC Drug CDMO Service Market Size by Country
6.3.1 North America ADC Drug CDMO Service Consumption Value by Country (2020-2031)
6.3.2 United States ADC Drug CDMO Service Market Size and Forecast (2020-2031)
6.3.3 Canada ADC Drug CDMO Service Market Size and Forecast (2020-2031)
6.3.4 Mexico ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe ADC Drug CDMO Service Consumption Value by Type (2020-2031)
7.2 Europe ADC Drug CDMO Service Consumption Value by Application (2020-2031)
7.3 Europe ADC Drug CDMO Service Market Size by Country
7.3.1 Europe ADC Drug CDMO Service Consumption Value by Country (2020-2031)
7.3.2 Germany ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7.3.3 France ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7.3.4 United Kingdom ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7.3.5 Russia ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7.3.6 Italy ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific ADC Drug CDMO Service Consumption Value by Type (2020-2031)
8.2 Asia-Pacific ADC Drug CDMO Service Consumption Value by Application (2020-2031)
8.3 Asia-Pacific ADC Drug CDMO Service Market Size by Region
8.3.1 Asia-Pacific ADC Drug CDMO Service Consumption Value by Region (2020-2031)
8.3.2 China ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.3 Japan ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.4 South Korea ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.5 India ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.7 Australia ADC Drug CDMO Service Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America ADC Drug CDMO Service Consumption Value by Type (2020-2031)
9.2 South America ADC Drug CDMO Service Consumption Value by Application (2020-2031)
9.3 South America ADC Drug CDMO Service Market Size by Country
9.3.1 South America ADC Drug CDMO Service Consumption Value by Country (2020-2031)
9.3.2 Brazil ADC Drug CDMO Service Market Size and Forecast (2020-2031)
9.3.3 Argentina ADC Drug CDMO Service Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa ADC Drug CDMO Service Consumption Value by Type (2020-2031)
10.2 Middle East & Africa ADC Drug CDMO Service Consumption Value by Application (2020-2031)
10.3 Middle East & Africa ADC Drug CDMO Service Market Size by Country
10.3.1 Middle East & Africa ADC Drug CDMO Service Consumption Value by Country (2020-2031)
10.3.2 Turkey ADC Drug CDMO Service Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia ADC Drug CDMO Service Market Size and Forecast (2020-2031)
10.3.4 UAE ADC Drug CDMO Service Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 ADC Drug CDMO Service Market Drivers
11.2 ADC Drug CDMO Service Market Restraints
11.3 ADC Drug CDMO Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 ADC Drug CDMO Service Industry Chain
12.2 ADC Drug CDMO Service Upstream Analysis
12.3 ADC Drug CDMO Service Midstream Analysis
12.4 ADC Drug CDMO Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of ADC Drug CDMO Service by Type
1.3.1 Overview: Global ADC Drug CDMO Service Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global ADC Drug CDMO Service Consumption Value Market Share by Type in 2024
1.3.3 Cleavable Linkers
1.3.4 Non-cleavable Linkers
1.4 Global ADC Drug CDMO Service Market by Application
1.4.1 Overview: Global ADC Drug CDMO Service Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Small and Medium-sized Pharmaceutical Companies
1.4.3 Large Pharmaceutical Companies
1.5 Global ADC Drug CDMO Service Market Size & Forecast
1.6 Global ADC Drug CDMO Service Market Size and Forecast by Region
1.6.1 Global ADC Drug CDMO Service Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global ADC Drug CDMO Service Market Size by Region, (2020-2031)
1.6.3 North America ADC Drug CDMO Service Market Size and Prospect (2020-2031)
1.6.4 Europe ADC Drug CDMO Service Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific ADC Drug CDMO Service Market Size and Prospect (2020-2031)
1.6.6 South America ADC Drug CDMO Service Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa ADC Drug CDMO Service Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group ADC Drug CDMO Service Product and Solutions
2.1.4 Lonza Group ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA ADC Drug CDMO Service Product and Solutions
2.2.4 Merck KGaA ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 WuXi XDC
2.3.1 WuXi XDC Details
2.3.2 WuXi XDC Major Business
2.3.3 WuXi XDC ADC Drug CDMO Service Product and Solutions
2.3.4 WuXi XDC ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 WuXi XDC Recent Developments and Future Plans
2.4 Abbvie
2.4.1 Abbvie Details
2.4.2 Abbvie Major Business
2.4.3 Abbvie ADC Drug CDMO Service Product and Solutions
2.4.4 Abbvie ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Abbvie Recent Developments and Future Plans
2.5 Piramal Pharma Solutions
2.5.1 Piramal Pharma Solutions Details
2.5.2 Piramal Pharma Solutions Major Business
2.5.3 Piramal Pharma Solutions ADC Drug CDMO Service Product and Solutions
2.5.4 Piramal Pharma Solutions ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.6 Catalent
2.6.1 Catalent Details
2.6.2 Catalent Major Business
2.6.3 Catalent ADC Drug CDMO Service Product and Solutions
2.6.4 Catalent ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Catalent Recent Developments and Future Plans
2.7 Sterling Pharma Solutions
2.7.1 Sterling Pharma Solutions Details
2.7.2 Sterling Pharma Solutions Major Business
2.7.3 Sterling Pharma Solutions ADC Drug CDMO Service Product and Solutions
2.7.4 Sterling Pharma Solutions ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Sterling Pharma Solutions Recent Developments and Future Plans
2.8 Axplora
2.8.1 Axplora Details
2.8.2 Axplora Major Business
2.8.3 Axplora ADC Drug CDMO Service Product and Solutions
2.8.4 Axplora ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Axplora Recent Developments and Future Plans
2.9 Aji Bio-Pharma
2.9.1 Aji Bio-Pharma Details
2.9.2 Aji Bio-Pharma Major Business
2.9.3 Aji Bio-Pharma ADC Drug CDMO Service Product and Solutions
2.9.4 Aji Bio-Pharma ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Aji Bio-Pharma Recent Developments and Future Plans
2.10 BSP Pharmaceuticals
2.10.1 BSP Pharmaceuticals Details
2.10.2 BSP Pharmaceuticals Major Business
2.10.3 BSP Pharmaceuticals ADC Drug CDMO Service Product and Solutions
2.10.4 BSP Pharmaceuticals ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 BSP Pharmaceuticals Recent Developments and Future Plans
2.11 Cerbios-Pharma
2.11.1 Cerbios-Pharma Details
2.11.2 Cerbios-Pharma Major Business
2.11.3 Cerbios-Pharma ADC Drug CDMO Service Product and Solutions
2.11.4 Cerbios-Pharma ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Cerbios-Pharma Recent Developments and Future Plans
2.12 Goodwin Biotechnology
2.12.1 Goodwin Biotechnology Details
2.12.2 Goodwin Biotechnology Major Business
2.12.3 Goodwin Biotechnology ADC Drug CDMO Service Product and Solutions
2.12.4 Goodwin Biotechnology ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Goodwin Biotechnology Recent Developments and Future Plans
2.13 TOT Biopharm
2.13.1 TOT Biopharm Details
2.13.2 TOT Biopharm Major Business
2.13.3 TOT Biopharm ADC Drug CDMO Service Product and Solutions
2.13.4 TOT Biopharm ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 TOT Biopharm Recent Developments and Future Plans
2.14 Huadong Medicine
2.14.1 Huadong Medicine Details
2.14.2 Huadong Medicine Major Business
2.14.3 Huadong Medicine ADC Drug CDMO Service Product and Solutions
2.14.4 Huadong Medicine ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Huadong Medicine Recent Developments and Future Plans
2.15 Innovent Biologics
2.15.1 Innovent Biologics Details
2.15.2 Innovent Biologics Major Business
2.15.3 Innovent Biologics ADC Drug CDMO Service Product and Solutions
2.15.4 Innovent Biologics ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Innovent Biologics Recent Developments and Future Plans
2.16 Shanghai Henlius Biotech
2.16.1 Shanghai Henlius Biotech Details
2.16.2 Shanghai Henlius Biotech Major Business
2.16.3 Shanghai Henlius Biotech ADC Drug CDMO Service Product and Solutions
2.16.4 Shanghai Henlius Biotech ADC Drug CDMO Service Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Shanghai Henlius Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global ADC Drug CDMO Service Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of ADC Drug CDMO Service by Company Revenue
3.2.2 Top 3 ADC Drug CDMO Service Players Market Share in 2024
3.2.3 Top 6 ADC Drug CDMO Service Players Market Share in 2024
3.3 ADC Drug CDMO Service Market: Overall Company Footprint Analysis
3.3.1 ADC Drug CDMO Service Market: Region Footprint
3.3.2 ADC Drug CDMO Service Market: Company Product Type Footprint
3.3.3 ADC Drug CDMO Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global ADC Drug CDMO Service Consumption Value and Market Share by Type (2020-2025)
4.2 Global ADC Drug CDMO Service Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2025)
5.2 Global ADC Drug CDMO Service Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America ADC Drug CDMO Service Consumption Value by Type (2020-2031)
6.2 North America ADC Drug CDMO Service Market Size by Application (2020-2031)
6.3 North America ADC Drug CDMO Service Market Size by Country
6.3.1 North America ADC Drug CDMO Service Consumption Value by Country (2020-2031)
6.3.2 United States ADC Drug CDMO Service Market Size and Forecast (2020-2031)
6.3.3 Canada ADC Drug CDMO Service Market Size and Forecast (2020-2031)
6.3.4 Mexico ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe ADC Drug CDMO Service Consumption Value by Type (2020-2031)
7.2 Europe ADC Drug CDMO Service Consumption Value by Application (2020-2031)
7.3 Europe ADC Drug CDMO Service Market Size by Country
7.3.1 Europe ADC Drug CDMO Service Consumption Value by Country (2020-2031)
7.3.2 Germany ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7.3.3 France ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7.3.4 United Kingdom ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7.3.5 Russia ADC Drug CDMO Service Market Size and Forecast (2020-2031)
7.3.6 Italy ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific ADC Drug CDMO Service Consumption Value by Type (2020-2031)
8.2 Asia-Pacific ADC Drug CDMO Service Consumption Value by Application (2020-2031)
8.3 Asia-Pacific ADC Drug CDMO Service Market Size by Region
8.3.1 Asia-Pacific ADC Drug CDMO Service Consumption Value by Region (2020-2031)
8.3.2 China ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.3 Japan ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.4 South Korea ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.5 India ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia ADC Drug CDMO Service Market Size and Forecast (2020-2031)
8.3.7 Australia ADC Drug CDMO Service Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America ADC Drug CDMO Service Consumption Value by Type (2020-2031)
9.2 South America ADC Drug CDMO Service Consumption Value by Application (2020-2031)
9.3 South America ADC Drug CDMO Service Market Size by Country
9.3.1 South America ADC Drug CDMO Service Consumption Value by Country (2020-2031)
9.3.2 Brazil ADC Drug CDMO Service Market Size and Forecast (2020-2031)
9.3.3 Argentina ADC Drug CDMO Service Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa ADC Drug CDMO Service Consumption Value by Type (2020-2031)
10.2 Middle East & Africa ADC Drug CDMO Service Consumption Value by Application (2020-2031)
10.3 Middle East & Africa ADC Drug CDMO Service Market Size by Country
10.3.1 Middle East & Africa ADC Drug CDMO Service Consumption Value by Country (2020-2031)
10.3.2 Turkey ADC Drug CDMO Service Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia ADC Drug CDMO Service Market Size and Forecast (2020-2031)
10.3.4 UAE ADC Drug CDMO Service Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 ADC Drug CDMO Service Market Drivers
11.2 ADC Drug CDMO Service Market Restraints
11.3 ADC Drug CDMO Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 ADC Drug CDMO Service Industry Chain
12.2 ADC Drug CDMO Service Upstream Analysis
12.3 ADC Drug CDMO Service Midstream Analysis
12.4 ADC Drug CDMO Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global ADC Drug CDMO Service Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global ADC Drug CDMO Service Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global ADC Drug CDMO Service Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global ADC Drug CDMO Service Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Lonza Group Company Information, Head Office, and Major Competitors
Table 6. Lonza Group Major Business
Table 7. Lonza Group ADC Drug CDMO Service Product and Solutions
Table 8. Lonza Group ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Lonza Group Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA ADC Drug CDMO Service Product and Solutions
Table 13. Merck KGaA ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. WuXi XDC Company Information, Head Office, and Major Competitors
Table 16. WuXi XDC Major Business
Table 17. WuXi XDC ADC Drug CDMO Service Product and Solutions
Table 18. WuXi XDC ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Abbvie Company Information, Head Office, and Major Competitors
Table 20. Abbvie Major Business
Table 21. Abbvie ADC Drug CDMO Service Product and Solutions
Table 22. Abbvie ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Abbvie Recent Developments and Future Plans
Table 24. Piramal Pharma Solutions Company Information, Head Office, and Major Competitors
Table 25. Piramal Pharma Solutions Major Business
Table 26. Piramal Pharma Solutions ADC Drug CDMO Service Product and Solutions
Table 27. Piramal Pharma Solutions ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Piramal Pharma Solutions Recent Developments and Future Plans
Table 29. Catalent Company Information, Head Office, and Major Competitors
Table 30. Catalent Major Business
Table 31. Catalent ADC Drug CDMO Service Product and Solutions
Table 32. Catalent ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Catalent Recent Developments and Future Plans
Table 34. Sterling Pharma Solutions Company Information, Head Office, and Major Competitors
Table 35. Sterling Pharma Solutions Major Business
Table 36. Sterling Pharma Solutions ADC Drug CDMO Service Product and Solutions
Table 37. Sterling Pharma Solutions ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Sterling Pharma Solutions Recent Developments and Future Plans
Table 39. Axplora Company Information, Head Office, and Major Competitors
Table 40. Axplora Major Business
Table 41. Axplora ADC Drug CDMO Service Product and Solutions
Table 42. Axplora ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Axplora Recent Developments and Future Plans
Table 44. Aji Bio-Pharma Company Information, Head Office, and Major Competitors
Table 45. Aji Bio-Pharma Major Business
Table 46. Aji Bio-Pharma ADC Drug CDMO Service Product and Solutions
Table 47. Aji Bio-Pharma ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Aji Bio-Pharma Recent Developments and Future Plans
Table 49. BSP Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 50. BSP Pharmaceuticals Major Business
Table 51. BSP Pharmaceuticals ADC Drug CDMO Service Product and Solutions
Table 52. BSP Pharmaceuticals ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. BSP Pharmaceuticals Recent Developments and Future Plans
Table 54. Cerbios-Pharma Company Information, Head Office, and Major Competitors
Table 55. Cerbios-Pharma Major Business
Table 56. Cerbios-Pharma ADC Drug CDMO Service Product and Solutions
Table 57. Cerbios-Pharma ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Cerbios-Pharma Recent Developments and Future Plans
Table 59. Goodwin Biotechnology Company Information, Head Office, and Major Competitors
Table 60. Goodwin Biotechnology Major Business
Table 61. Goodwin Biotechnology ADC Drug CDMO Service Product and Solutions
Table 62. Goodwin Biotechnology ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Goodwin Biotechnology Recent Developments and Future Plans
Table 64. TOT Biopharm Company Information, Head Office, and Major Competitors
Table 65. TOT Biopharm Major Business
Table 66. TOT Biopharm ADC Drug CDMO Service Product and Solutions
Table 67. TOT Biopharm ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. TOT Biopharm Recent Developments and Future Plans
Table 69. Huadong Medicine Company Information, Head Office, and Major Competitors
Table 70. Huadong Medicine Major Business
Table 71. Huadong Medicine ADC Drug CDMO Service Product and Solutions
Table 72. Huadong Medicine ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Huadong Medicine Recent Developments and Future Plans
Table 74. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 75. Innovent Biologics Major Business
Table 76. Innovent Biologics ADC Drug CDMO Service Product and Solutions
Table 77. Innovent Biologics ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Innovent Biologics Recent Developments and Future Plans
Table 79. Shanghai Henlius Biotech Company Information, Head Office, and Major Competitors
Table 80. Shanghai Henlius Biotech Major Business
Table 81. Shanghai Henlius Biotech ADC Drug CDMO Service Product and Solutions
Table 82. Shanghai Henlius Biotech ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Shanghai Henlius Biotech Recent Developments and Future Plans
Table 84. Global ADC Drug CDMO Service Revenue (USD Million) by Players (2020-2025)
Table 85. Global ADC Drug CDMO Service Revenue Share by Players (2020-2025)
Table 86. Breakdown of ADC Drug CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 87. Market Position of Players in ADC Drug CDMO Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 88. Head Office of Key ADC Drug CDMO Service Players
Table 89. ADC Drug CDMO Service Market: Company Product Type Footprint
Table 90. ADC Drug CDMO Service Market: Company Product Application Footprint
Table 91. ADC Drug CDMO Service New Market Entrants and Barriers to Market Entry
Table 92. ADC Drug CDMO Service Mergers, Acquisition, Agreements, and Collaborations
Table 93. Global ADC Drug CDMO Service Consumption Value (USD Million) by Type (2020-2025)
Table 94. Global ADC Drug CDMO Service Consumption Value Share by Type (2020-2025)
Table 95. Global ADC Drug CDMO Service Consumption Value Forecast by Type (2026-2031)
Table 96. Global ADC Drug CDMO Service Consumption Value by Application (2020-2025)
Table 97. Global ADC Drug CDMO Service Consumption Value Forecast by Application (2026-2031)
Table 98. North America ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 99. North America ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 100. North America ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 101. North America ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 102. North America ADC Drug CDMO Service Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America ADC Drug CDMO Service Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 105. Europe ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 106. Europe ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 107. Europe ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 108. Europe ADC Drug CDMO Service Consumption Value by Country (2020-2025) & (USD Million)
Table 109. Europe ADC Drug CDMO Service Consumption Value by Country (2026-2031) & (USD Million)
Table 110. Asia-Pacific ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 111. Asia-Pacific ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 112. Asia-Pacific ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 113. Asia-Pacific ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 114. Asia-Pacific ADC Drug CDMO Service Consumption Value by Region (2020-2025) & (USD Million)
Table 115. Asia-Pacific ADC Drug CDMO Service Consumption Value by Region (2026-2031) & (USD Million)
Table 116. South America ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 117. South America ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 118. South America ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 119. South America ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 120. South America ADC Drug CDMO Service Consumption Value by Country (2020-2025) & (USD Million)
Table 121. South America ADC Drug CDMO Service Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Middle East & Africa ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 123. Middle East & Africa ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 124. Middle East & Africa ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 125. Middle East & Africa ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 126. Middle East & Africa ADC Drug CDMO Service Consumption Value by Country (2020-2025) & (USD Million)
Table 127. Middle East & Africa ADC Drug CDMO Service Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Global Key Players of ADC Drug CDMO Service Upstream (Raw Materials)
Table 129. Global ADC Drug CDMO Service Typical Customers
Table 1. Global ADC Drug CDMO Service Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global ADC Drug CDMO Service Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global ADC Drug CDMO Service Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global ADC Drug CDMO Service Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Lonza Group Company Information, Head Office, and Major Competitors
Table 6. Lonza Group Major Business
Table 7. Lonza Group ADC Drug CDMO Service Product and Solutions
Table 8. Lonza Group ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Lonza Group Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA ADC Drug CDMO Service Product and Solutions
Table 13. Merck KGaA ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. WuXi XDC Company Information, Head Office, and Major Competitors
Table 16. WuXi XDC Major Business
Table 17. WuXi XDC ADC Drug CDMO Service Product and Solutions
Table 18. WuXi XDC ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Abbvie Company Information, Head Office, and Major Competitors
Table 20. Abbvie Major Business
Table 21. Abbvie ADC Drug CDMO Service Product and Solutions
Table 22. Abbvie ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Abbvie Recent Developments and Future Plans
Table 24. Piramal Pharma Solutions Company Information, Head Office, and Major Competitors
Table 25. Piramal Pharma Solutions Major Business
Table 26. Piramal Pharma Solutions ADC Drug CDMO Service Product and Solutions
Table 27. Piramal Pharma Solutions ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Piramal Pharma Solutions Recent Developments and Future Plans
Table 29. Catalent Company Information, Head Office, and Major Competitors
Table 30. Catalent Major Business
Table 31. Catalent ADC Drug CDMO Service Product and Solutions
Table 32. Catalent ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Catalent Recent Developments and Future Plans
Table 34. Sterling Pharma Solutions Company Information, Head Office, and Major Competitors
Table 35. Sterling Pharma Solutions Major Business
Table 36. Sterling Pharma Solutions ADC Drug CDMO Service Product and Solutions
Table 37. Sterling Pharma Solutions ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Sterling Pharma Solutions Recent Developments and Future Plans
Table 39. Axplora Company Information, Head Office, and Major Competitors
Table 40. Axplora Major Business
Table 41. Axplora ADC Drug CDMO Service Product and Solutions
Table 42. Axplora ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Axplora Recent Developments and Future Plans
Table 44. Aji Bio-Pharma Company Information, Head Office, and Major Competitors
Table 45. Aji Bio-Pharma Major Business
Table 46. Aji Bio-Pharma ADC Drug CDMO Service Product and Solutions
Table 47. Aji Bio-Pharma ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Aji Bio-Pharma Recent Developments and Future Plans
Table 49. BSP Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 50. BSP Pharmaceuticals Major Business
Table 51. BSP Pharmaceuticals ADC Drug CDMO Service Product and Solutions
Table 52. BSP Pharmaceuticals ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. BSP Pharmaceuticals Recent Developments and Future Plans
Table 54. Cerbios-Pharma Company Information, Head Office, and Major Competitors
Table 55. Cerbios-Pharma Major Business
Table 56. Cerbios-Pharma ADC Drug CDMO Service Product and Solutions
Table 57. Cerbios-Pharma ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Cerbios-Pharma Recent Developments and Future Plans
Table 59. Goodwin Biotechnology Company Information, Head Office, and Major Competitors
Table 60. Goodwin Biotechnology Major Business
Table 61. Goodwin Biotechnology ADC Drug CDMO Service Product and Solutions
Table 62. Goodwin Biotechnology ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Goodwin Biotechnology Recent Developments and Future Plans
Table 64. TOT Biopharm Company Information, Head Office, and Major Competitors
Table 65. TOT Biopharm Major Business
Table 66. TOT Biopharm ADC Drug CDMO Service Product and Solutions
Table 67. TOT Biopharm ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. TOT Biopharm Recent Developments and Future Plans
Table 69. Huadong Medicine Company Information, Head Office, and Major Competitors
Table 70. Huadong Medicine Major Business
Table 71. Huadong Medicine ADC Drug CDMO Service Product and Solutions
Table 72. Huadong Medicine ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Huadong Medicine Recent Developments and Future Plans
Table 74. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 75. Innovent Biologics Major Business
Table 76. Innovent Biologics ADC Drug CDMO Service Product and Solutions
Table 77. Innovent Biologics ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Innovent Biologics Recent Developments and Future Plans
Table 79. Shanghai Henlius Biotech Company Information, Head Office, and Major Competitors
Table 80. Shanghai Henlius Biotech Major Business
Table 81. Shanghai Henlius Biotech ADC Drug CDMO Service Product and Solutions
Table 82. Shanghai Henlius Biotech ADC Drug CDMO Service Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Shanghai Henlius Biotech Recent Developments and Future Plans
Table 84. Global ADC Drug CDMO Service Revenue (USD Million) by Players (2020-2025)
Table 85. Global ADC Drug CDMO Service Revenue Share by Players (2020-2025)
Table 86. Breakdown of ADC Drug CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 87. Market Position of Players in ADC Drug CDMO Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 88. Head Office of Key ADC Drug CDMO Service Players
Table 89. ADC Drug CDMO Service Market: Company Product Type Footprint
Table 90. ADC Drug CDMO Service Market: Company Product Application Footprint
Table 91. ADC Drug CDMO Service New Market Entrants and Barriers to Market Entry
Table 92. ADC Drug CDMO Service Mergers, Acquisition, Agreements, and Collaborations
Table 93. Global ADC Drug CDMO Service Consumption Value (USD Million) by Type (2020-2025)
Table 94. Global ADC Drug CDMO Service Consumption Value Share by Type (2020-2025)
Table 95. Global ADC Drug CDMO Service Consumption Value Forecast by Type (2026-2031)
Table 96. Global ADC Drug CDMO Service Consumption Value by Application (2020-2025)
Table 97. Global ADC Drug CDMO Service Consumption Value Forecast by Application (2026-2031)
Table 98. North America ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 99. North America ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 100. North America ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 101. North America ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 102. North America ADC Drug CDMO Service Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America ADC Drug CDMO Service Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 105. Europe ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 106. Europe ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 107. Europe ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 108. Europe ADC Drug CDMO Service Consumption Value by Country (2020-2025) & (USD Million)
Table 109. Europe ADC Drug CDMO Service Consumption Value by Country (2026-2031) & (USD Million)
Table 110. Asia-Pacific ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 111. Asia-Pacific ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 112. Asia-Pacific ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 113. Asia-Pacific ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 114. Asia-Pacific ADC Drug CDMO Service Consumption Value by Region (2020-2025) & (USD Million)
Table 115. Asia-Pacific ADC Drug CDMO Service Consumption Value by Region (2026-2031) & (USD Million)
Table 116. South America ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 117. South America ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 118. South America ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 119. South America ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 120. South America ADC Drug CDMO Service Consumption Value by Country (2020-2025) & (USD Million)
Table 121. South America ADC Drug CDMO Service Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Middle East & Africa ADC Drug CDMO Service Consumption Value by Type (2020-2025) & (USD Million)
Table 123. Middle East & Africa ADC Drug CDMO Service Consumption Value by Type (2026-2031) & (USD Million)
Table 124. Middle East & Africa ADC Drug CDMO Service Consumption Value by Application (2020-2025) & (USD Million)
Table 125. Middle East & Africa ADC Drug CDMO Service Consumption Value by Application (2026-2031) & (USD Million)
Table 126. Middle East & Africa ADC Drug CDMO Service Consumption Value by Country (2020-2025) & (USD Million)
Table 127. Middle East & Africa ADC Drug CDMO Service Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Global Key Players of ADC Drug CDMO Service Upstream (Raw Materials)
Table 129. Global ADC Drug CDMO Service Typical Customers
LIST OF FIGURES
Figure 1. ADC Drug CDMO Service Picture
Figure 2. Global ADC Drug CDMO Service Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global ADC Drug CDMO Service Consumption Value Market Share by Type in 2024
Figure 4. Cleavable Linkers
Figure 5. Non-cleavable Linkers
Figure 6. Global ADC Drug CDMO Service Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. ADC Drug CDMO Service Consumption Value Market Share by Application in 2024
Figure 8. Small and Medium-sized Pharmaceutical Companies Picture
Figure 9. Large Pharmaceutical Companies Picture
Figure 10. Global ADC Drug CDMO Service Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global ADC Drug CDMO Service Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Market ADC Drug CDMO Service Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 13. Global ADC Drug CDMO Service Consumption Value Market Share by Region (2020-2031)
Figure 14. Global ADC Drug CDMO Service Consumption Value Market Share by Region in 2024
Figure 15. North America ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 16. Europe ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 17. Asia-Pacific ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 18. South America ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 19. Middle East & Africa ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global ADC Drug CDMO Service Revenue Share by Players in 2024
Figure 22. ADC Drug CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 23. Market Share of ADC Drug CDMO Service by Player Revenue in 2024
Figure 24. Top 3 ADC Drug CDMO Service Players Market Share in 2024
Figure 25. Top 6 ADC Drug CDMO Service Players Market Share in 2024
Figure 26. Global ADC Drug CDMO Service Consumption Value Share by Type (2020-2025)
Figure 27. Global ADC Drug CDMO Service Market Share Forecast by Type (2026-2031)
Figure 28. Global ADC Drug CDMO Service Consumption Value Share by Application (2020-2025)
Figure 29. Global ADC Drug CDMO Service Market Share Forecast by Application (2026-2031)
Figure 30. North America ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 31. North America ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 32. North America ADC Drug CDMO Service Consumption Value Market Share by Country (2020-2031)
Figure 33. United States ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 34. Canada ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 35. Mexico ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 36. Europe ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 37. Europe ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 38. Europe ADC Drug CDMO Service Consumption Value Market Share by Country (2020-2031)
Figure 39. Germany ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 40. France ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 41. United Kingdom ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 42. Russia ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 43. Italy ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 44. Asia-Pacific ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 45. Asia-Pacific ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 46. Asia-Pacific ADC Drug CDMO Service Consumption Value Market Share by Region (2020-2031)
Figure 47. China ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 48. Japan ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 49. South Korea ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 50. India ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 51. Southeast Asia ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 52. Australia ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 53. South America ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 54. South America ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 55. South America ADC Drug CDMO Service Consumption Value Market Share by Country (2020-2031)
Figure 56. Brazil ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 57. Argentina ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 58. Middle East & Africa ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 59. Middle East & Africa ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 60. Middle East & Africa ADC Drug CDMO Service Consumption Value Market Share by Country (2020-2031)
Figure 61. Turkey ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 62. Saudi Arabia ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 63. UAE ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 64. ADC Drug CDMO Service Market Drivers
Figure 65. ADC Drug CDMO Service Market Restraints
Figure 66. ADC Drug CDMO Service Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. ADC Drug CDMO Service Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. ADC Drug CDMO Service Picture
Figure 2. Global ADC Drug CDMO Service Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global ADC Drug CDMO Service Consumption Value Market Share by Type in 2024
Figure 4. Cleavable Linkers
Figure 5. Non-cleavable Linkers
Figure 6. Global ADC Drug CDMO Service Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. ADC Drug CDMO Service Consumption Value Market Share by Application in 2024
Figure 8. Small and Medium-sized Pharmaceutical Companies Picture
Figure 9. Large Pharmaceutical Companies Picture
Figure 10. Global ADC Drug CDMO Service Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global ADC Drug CDMO Service Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Market ADC Drug CDMO Service Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 13. Global ADC Drug CDMO Service Consumption Value Market Share by Region (2020-2031)
Figure 14. Global ADC Drug CDMO Service Consumption Value Market Share by Region in 2024
Figure 15. North America ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 16. Europe ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 17. Asia-Pacific ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 18. South America ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 19. Middle East & Africa ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global ADC Drug CDMO Service Revenue Share by Players in 2024
Figure 22. ADC Drug CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 23. Market Share of ADC Drug CDMO Service by Player Revenue in 2024
Figure 24. Top 3 ADC Drug CDMO Service Players Market Share in 2024
Figure 25. Top 6 ADC Drug CDMO Service Players Market Share in 2024
Figure 26. Global ADC Drug CDMO Service Consumption Value Share by Type (2020-2025)
Figure 27. Global ADC Drug CDMO Service Market Share Forecast by Type (2026-2031)
Figure 28. Global ADC Drug CDMO Service Consumption Value Share by Application (2020-2025)
Figure 29. Global ADC Drug CDMO Service Market Share Forecast by Application (2026-2031)
Figure 30. North America ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 31. North America ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 32. North America ADC Drug CDMO Service Consumption Value Market Share by Country (2020-2031)
Figure 33. United States ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 34. Canada ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 35. Mexico ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 36. Europe ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 37. Europe ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 38. Europe ADC Drug CDMO Service Consumption Value Market Share by Country (2020-2031)
Figure 39. Germany ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 40. France ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 41. United Kingdom ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 42. Russia ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 43. Italy ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 44. Asia-Pacific ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 45. Asia-Pacific ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 46. Asia-Pacific ADC Drug CDMO Service Consumption Value Market Share by Region (2020-2031)
Figure 47. China ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 48. Japan ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 49. South Korea ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 50. India ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 51. Southeast Asia ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 52. Australia ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 53. South America ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 54. South America ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 55. South America ADC Drug CDMO Service Consumption Value Market Share by Country (2020-2031)
Figure 56. Brazil ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 57. Argentina ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 58. Middle East & Africa ADC Drug CDMO Service Consumption Value Market Share by Type (2020-2031)
Figure 59. Middle East & Africa ADC Drug CDMO Service Consumption Value Market Share by Application (2020-2031)
Figure 60. Middle East & Africa ADC Drug CDMO Service Consumption Value Market Share by Country (2020-2031)
Figure 61. Turkey ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 62. Saudi Arabia ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 63. UAE ADC Drug CDMO Service Consumption Value (2020-2031) & (USD Million)
Figure 64. ADC Drug CDMO Service Market Drivers
Figure 65. ADC Drug CDMO Service Market Restraints
Figure 66. ADC Drug CDMO Service Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. ADC Drug CDMO Service Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
